« FDA Approvals - Editorials Address Legislation That Would Increase FDA Funding For Foreign | Main | FDA Approves New Formulation of Coagulation Therapy he U.S. Food »

Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the


Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the Treatment of Postmenopausal Osteoporosis (PR Newswire via Yahoo! Finance)
Wyeth Pharmaceuticals, a division of Wyeth , announced today that the U.S. Food and Drug Administration issued an approvable letter on May 21 for bazedoxifene, a selective estrogen receptor modulator, for the treatment of postmenopausal osteoporosis.
 

©2006 FDA-News.com. All rights reserved.